Bioavailability of Oral Ondansetron in Dogs: A Crossover Study
Journal of Veterinary Pharmacology and Therapeutics · 2026-01 · 49 (1) · 17-21
DOI: 10.1111/jvp.70024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Pharmacology and Therapeutics, online erschienen am 09.09.2025. Verfasst von Amanda Garrick und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Sciences Department, Colorado State University, Fort Collins, Colorado, USA. Hauptthemen laut MEDLINE: Ondansetron, Antiemetics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Colorado State University.
Abstract (Originalsprache)
The purpose of this study was to evaluate the pharmacokinetics of oral (PO) ondansetron compared to intravenous (IV) ondansetron in eight healthy client‐owned dogs. Dogs were randomized to one of two protocols in a crossover design, receiving PO or IV ondansetron at a dose of 1 mg/kg on Day 0 and the opposite formulation at an equal dose on Day 7. Plasma was collected at baseline and 1, 2, 4, and 8 h post administration. Ondansetron concentrations were measured utilizing liquid chromatography/mass spectrometry. For IV administration, AUC 0–8h was 1181 ± 619 ng/mL*h, with all dogs having detectable plasma concentrations at all time points. For PO administration, mean C max was 22 ± 11.3 ng/mL and AUC 0–8h was 61.7 ± 45.4 ng/mL*h, with all dogs having undetectable concentrations at various time points. Oral mean bioavailability was estimated at 5.2% ± 2.1%. Oral bioavailability of ondansetron is very low in healthy dogs, raising concern for the efficacy of ondansetron when given orally at 1 mg/kg. Future studies evaluating pharmacodynamics of ondansetron in nauseous client‐owned dogs should be performed to investigate whether plasma drug concentrations are the optimal way to assess the efficacy of oral ondansetron.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Sciences Department, Colorado State University, Fort Collins, Colorado, USA.
ORCID-Profile: Amanda Garrick, Kristin Zersen
Förderung
- Colorado State University
Zitieren
APA
Garrick, A., Zersen, K., Gustafson, D., Quimby, J., Diaz, A., & Shropshire, S. (2026). Bioavailability of Oral Ondansetron in Dogs: A Crossover Study. Journal of Veterinary Pharmacology and Therapeutics, 49(1), 17-21. https://doi.org/10.1111/jvp.70024
Vancouver
Garrick A, Zersen K, Gustafson D, Quimby J, Diaz A, Shropshire S. Bioavailability of Oral Ondansetron in Dogs: A Crossover Study. Journal of Veterinary Pharmacology and Therapeutics. 2026;49(1):17-21. doi:10.1111/jvp.70024
BibTeX
@article{Garrick2026,
author = {Garrick, Amanda and Zersen, Kristin and Gustafson, Daniel and Quimby, Jessica and Diaz, Amanda and Shropshire, Sarah},
title = {Bioavailability of Oral Ondansetron in Dogs: A Crossover Study},
journal = {Journal of Veterinary Pharmacology and Therapeutics},
year = {2026},
volume = {49},
number = {1},
pages = {17--21},
doi = {10.1111/jvp.70024}
}
EUVIMED